Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, IN8bio Inc (NASDAQ: INAB) closed at $0.27 down -5.07% from its previous closing price of $0.29. In other words, the price has decreased by -$5.07 from its previous closing price. On the day, 2.13 million shares were traded.
Ratios:
For a deeper understanding of IN8bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Laidlaw on March 18, 2024, initiated with a Buy rating and assigned the stock a target price of $7.50.
On August 30, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $14.
Stock Price History:
Over the past 52 weeks, INAB has reached a high of $1.74, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -4.18%, while the 200-Day Moving Average is calculated to be -49.80%.
Shares Statistics:
A total of 72.48M shares are outstanding, with a floating share count of 57.73M. Insiders hold about 20.35% of the company’s shares, while institutions hold 34.01% stake in the company.
